Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Cash from Investing Activities (2023 - 2026)

Kura Oncology has reported Cash from Investing Activities over the past 4 years, most recently at -$24.2 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 76.11% to -$24.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $64.1 million through Mar 2026, up 159.52% year-over-year, with the annual reading at -$13.1 million for FY2025, 87.11% up from the prior year.
  • Cash from Investing Activities was -$24.2 million for Q1 2026 at Kura Oncology, up from -$64.6 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $94.0 million in Q3 2025 and troughed at -$101.4 million in Q1 2025.
  • The 4-year median for Cash from Investing Activities is $8.6 million (2023), against an average of -$9.5 million.
  • The largest YoY upside for Cash from Investing Activities was 432.01% in 2024 against a maximum downside of 956.65% in 2024.
  • A 4-year view of Cash from Investing Activities shows it stood at $42.2 million in 2023, then plummeted by 325.04% to -$95.0 million in 2024, then soared by 31.97% to -$64.6 million in 2025, then surged by 62.49% to -$24.2 million in 2026.
  • Per Business Quant, the three most recent readings for KURA's Cash from Investing Activities are -$24.2 million (Q1 2026), -$64.6 million (Q4 2025), and $94.0 million (Q3 2025).